Presentation TCT 2014 Outcomes of TAVR and SAVR: Argentinean Registries Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Miguel Oscar Payaslian September 13, 2014
Presentation TCT 2014 TAVR Is Preferred for All but the Lowest-Risk Patients! Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Alec S. Vahanian September 13, 2014
Presentation TCT 2014 Surgery for All but the Highest-Risk Patients! Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Jose Navia September 13, 2014
Presentation TCT 2014 TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Alison Duncan September 13, 2014
Presentation TCT 2014 Thoughtful Perspectives on the Futile Patient with Aortic Stenosis Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Robert A. Guyton September 13, 2014
Presentation TCT 2014 Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow September 13, 2014
Presentation TCT 2014 The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov September 13, 2014
Presentation TCT 2014 CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014
News Conference News TCT 2014 Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices September 13, 2014
News Conference News TCT 2014 Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR September 13, 2014
News Daily News La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC September 11, 2014
News Daily News Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD September 11, 2014
Presentation ESC 2014 Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry Presenter: Eric Van Belle September 02, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Daily News Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis Caitlin E. Cox August 31, 2014
News Conference News ESC 2014 Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device Todd Neale August 31, 2014